WithdrawnNot Applicable

Tracking Biomarkers of Speech Intelligibility

Stopped: Funding for this study ended prior to enrollment of any participants due to a change in funding.

0Started 2022-01

Plain-language summary

Difficulties understanding speech in noisy environments repeatedly coincide with high-frequency hearing loss. This complaint is commonly exhibited in adults in middle/older age who have a history of noise exposure. In this study, an immersive audiomotor training game will be utilized to drive improvements in speech intelligibility, controlled by an auditory memory training game. Physiological measures will be tracked that could inform clinical assessment of hearing in noise abilities.

Who can participate

Age range40 Years – 69 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * High frequency hearing loss subjects - Thresholds of 15 dB HL or less for 0.25-2 kHz. Thresholds of 30-60 dB HL from 3-8 kHz. * Normal hearing subjects - Thresholds of 15 dB HL or less from 0.5-8 kHz. * Thresholds between left and right ears symmetric within 10 dB for all frequencies. * Native English speakers. Exclusion Criteria: * Conductive hearing loss (as assessed by audiologist). * Active otologic disease (as assessed by audiologist). * Significant cognitive decline (Montreal Cognitive Assessment score \> 25).

What they're measuring

Change in Speech Recognition in Noise Performance Accuracy

Timeframe: Pre-test / Post-test (8 weeks) / Follow-up (16 weeks)

Trial details

NCT IDNCT05145946

SponsorMassachusetts Eye and Ear Infirmary

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2022-12

View on ClinicalTrials.gov More High-Frequency Hearing Loss trials